SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002199
Filing Date
2015-11-04
Accepted
2015-11-03 18:55:04
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20150930x10q.htm 10-Q 1556951
2 EX-10.1 xncr-20150930ex1018a1ffd.htm EX-10.1 809484
3 EX-31.1 xncr-20150930ex3112ffcc6.htm EX-31.1 19295
4 EX-31.2 xncr-20150930ex312d4c59c.htm EX-31.2 19490
5 EX-32.1 xncr-20150930ex321f8e15b.htm EX-32.1 11936
6 GRAPHIC xncr20150930ex1018a1ffd001.jpg GRAPHIC 52350
7 GRAPHIC xncr20150930ex1018a1ffd002.jpg GRAPHIC 8372
  Complete submission text file 0001558370-15-002199.txt   5943591

Data Files

Seq Description Document Type Size
8 EX-101.INS xncr-20150930.xml EX-101.INS 961892
9 EX-101.SCH xncr-20150930.xsd EX-101.SCH 32495
10 EX-101.CAL xncr-20150930_cal.xml EX-101.CAL 41652
11 EX-101.DEF xncr-20150930_def.xml EX-101.DEF 117050
12 EX-101.LAB xncr-20150930_lab.xml EX-101.LAB 344969
13 EX-101.PRE xncr-20150930_pre.xml EX-101.PRE 233954
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 151195096
SIC: 2834 Pharmaceutical Preparations